MetaStat, Inc.
MetaStat, Inc. (MTST) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MTST · as of Jun 9, 2026
Key Statistics
Explore MetaStat, Inc. Data
mtst stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
mtst competitorsMTST
ATRX
CDXI
ELOX
LGBI
MODCStock Performance
Full HistoryAbout MetaStat, Inc.
MetaStat, Inc. is a precision medicine company focused on creating advanced therapeutic and diagnostic solutions for cancer patients. The company's primary research and development efforts target the …
what is metastat, inc. · mtst stock overview · metastat, inc. company profile · who is metastat, inc. ceo · mtst OTC · metastat, inc. headquarters · metastat, inc. business segments
About Stock Overview & Key Data
MetaStat, Inc. (MTST) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 5, 2009. As of the latest trading session, MTST stock price is $0.00, with a market capitalization of $5,877. The stock has returned +400.00% over the past 12 months and +66.67% year-to-date.
In fiscal year 2018, MetaStat, Inc. reported revenue of $23300.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MetaStat, Inc. (MTST) stock price is $0.00. The stock is traded on OTC under the ticker symbol MTST. The 52-week range is $0.00 – $0.00.